This molecule targets at type 2 diabetes - a single crystal study on (2<i>R</i>,3<i>S</i>,5<i>R</i>)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-<i>c</i>]pyrazol-5(4<i>H</i>)-yl] tetrahydro-2<i>H</i>-pyran-3-amine (Omarigliptin), C<sub>17</sub>H<sub>20</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub>S
Zeitschrift für Kristallographie. New crystal structures/Zeitschrift für Kristallographie. New crystal structures